ENGOT-ov50/GOG-3029/INNOVATE-3
Trial Description:
Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 200kHz) Concomitant With Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer
Lead Cooperative Group:
Trial Number:
Disease Site:
Recurrent Ovarian
Trial Status:
Closed to Recruitment
Contact person:
ivergote